Heparin Sodium
- Product NDC
- 67457-950
- 11-digit product format
- 674570950
- Labeler code
- 67457
- Product ID
- 67457-950_c1c9c265-453e-4464-8b8f-682b3fb42f0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Heparin Sodium
- Dosage form
- INJECTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA203851
- Marketing category
- ANDA
- Marketing start
- 2019-04-17
- Marketing end
- 2021-08-31
- Substance
- HEPARIN SODIUM
- Active strength
- 10000 [USP'U]/mL
- Pharmacologic classes
- Anti-coagulant [EPC],Heparin [CS],Unfractionated Heparin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-950-01 | 67457095001 | 25 VIAL, SINGLE-DOSE in 1 CARTON (67457-950-01) > 1 mL in 1 VIAL, SINGLE-DOSE (67457-950-00) | 2019-04-17 | 2021-08-31 | No | No | Current |